Steris (STE) FCF Payout Ratio (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.77% |
| Dec 31, 2025 | -290.23% |
| Sep 30, 2025 | 78.59% |
| Jun 30, 2025 | -85.02% |
| Mar 31, 2025 | 363.91% |
| Dec 31, 2024 | -215.19% |
| Sep 30, 2024 | 43.89% |
| Jun 30, 2024 | 129.07% |
| Mar 31, 2024 | -403.13% |
| Dec 31, 2023 | -63.54% |
| Sep 30, 2023 | 277.94% |
| Jun 30, 2023 | 122.95% |
| Mar 31, 2023 | -328.62% |
| Dec 31, 2022 | -81.51% |
| Sep 30, 2022 | 500.73% |
| Jun 30, 2022 | -14.90% |
| Mar 31, 2022 | 65.56% |
| Dec 31, 2021 | -42.10% |
| Sep 30, 2021 | -45.30% |
| Jun 30, 2021 | 2,549.81% |
| Mar 31, 2021 | 107.35% |
| Dec 31, 2020 | -247.99% |
| Sep 30, 2020 | -38.29% |
| Jun 30, 2020 | 171.66% |
| Mar 31, 2020 | -257.85% |
| Dec 31, 2019 | 34.77% |
| Sep 30, 2019 | -36.59% |
| Dec 31, 2018 | -308.61% |
| Sep 30, 2018 | -12.25% |